Celebrity Inventors
Superstar singer Michael Jackson co-patented a "Method and means for creating anti-gravity illusion" in 1993.
PatentStorm News
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7416862 | Nucleic acid and amino acid sequences relating to for diagnostics and therapeutics The invention provides isolated polypeptide and nucleic acid sequences derived from Staphylococcus epidermidis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the poly... | 08/26/2008 |
| 7183083 | Nucleic acid and amino acid sequences relating to for diagnostics and therapeutics The invention provides isolated polypeptide and nucleic acid sequences derived from Staphylococcus epidermidis that are useful in diagnosis and therapy of pathological conditions; antibodies against the polypeptides; and methods for the production of the poly... | 02/27/2007 |
| 6579711 | Lactic acid bacteria species Strain of lactic acid bacterium, (1) whose 16S ribosomal RNA is characteristic of the genus Streptococcus, (2) whose total protein profile, obtained after migration of the total proteins on an SDS-PAGE electrophoresis gel, is characteristic of that of the... | 06/17/2003 |
| 5925556 | Method of degrading polylactic acid resin using staphylococcus hominis and staphylococcus epidermidis A microorganism belonging to the genus Staphylococcus or the genus Streptomyces which is capable of degrading a polylactic acid resin. A method of degrading a polylactic acid resin including a step of culturing a microorganism capable of degrading a polyl... | 07/20/1999 |
| 5837482 | Culture medium and methods for detecting staphylococci A medium for detecting staphylococci is described. The medium contains components selective for growing staphylococci, and a glucopyranoside indicator substance in sufficient quantity to distinguish colonies containing Bacillus and other microorganisms fr... | 11/17/1998 |
| 5804186 | Nerve cell differentiation promoter A nerve cell differentiation promoter which comprises a physiologically active substance NK175203 or a pharmacologically acceptable salt thereof as an active ingredient is provided. It is expected that the nerve cell differentiation promoter of the presen... | 09/08/1998 |
| 5789191 | Method of detecting and counting microorganisms The invention provides a cosmetic or dermatological method for detecting and/or selectively quantifying individual microorganisms, and/or whole groups of microorganisms, which are present on human or animal skin, comprising the steps of removing a sample ... | 08/04/1998 |
| 5759799 | Marker for revealing contaminants and application method for performing an antibiogram carried out directly on a sample An incubation limit marker for revealing the growth of contaminants present in a sample includes at least one strain or category of classically contaminant bacteria in dehydrated form which, once regenerated, will be present at a maximum concentration of ... | 06/02/1998 |
| 5741662 | Direct stain specific binding assays for microorganisms The present invention provides specific binding solid phase assay methods and kits for the detection of the presence or absence of a microorganism by directly staining the microorganism and specifically capturing the stained microorganism on a solid suppo... | 04/21/1998 |
| 5292874 | Nucleic acid probes to Staphylococcus aureus Hybridization assay probes specific for Staphylococcus aureus and no other Staphylococcus species.... | 03/08/1994 |
| 5189015 | Method for prophylactic treatment of the colonization of a Staphylococcus aureus bacterial strain by bacterial cell surface protein with fibronectin and fibrinogen binding ability A method for prophylactic treatments of the colonization of a Staphylococcus aureus bacterial strain having the ability to bind to fibronectin in a mammal. The method comprises administering a prophylactic therapeutically active amount of a protein having... | 02/23/1993 |
| 5084565 | Probes for the specific detection of Escherichia coli and Shigella Nucleic acid probes capable of specifically hybridizing to rRNA of E. coli and Shigella species and not to rRNA of non-E. coli/Shigella are described along with methods utilizing such probes for the specific detection of E. coli and/or Shigella in food an... | 01/28/1992 |
| 4683198 | Novel maltose dehydrogenase, process for its production, and analytical method using the same An enzyme which acts on a reducing terminal of a monosaccharide or oligosaccharide without requiring NAD or NADP and which catalyzes the reaction ##STR1## wherein R is a saccharide chain residue or hydrogen, A is a hydrogen acceptor other than N... | 07/28/1987 |
| 4643970 | Production of HCG Method for the production of chorionic gonadotropin (CG) with properties similar to those of human CG (HCG) from a microorganism or mutant thereof isolated by natural or hybridization procedure from the body or body extract carrier of a malignant tumor ca... | 02/17/1987 |
| 4604234 | Protein having cell growth stimulating action, composition thereof and method for producing the same A protein effective in stimulating cell growth activity. The protein has a molecular weight of from 5,000 to about 160,000, is composed predominantly of neutral and acidic amino acids, contains a significant amount of glutamic acid and aspartic acid, and ... | 08/05/1986 |
| 4588692 | Antibiotic compounds, process for the preparation and pharmaceutical compositions thereof, methods of treatment therewith and Staphylococcus bacteria The invention relates to an antibiotic polypeptide compound, or addition salt thereof, having a molecular weight no greater than 10000 and possessing bactericidal and bacteriolytic activities in respect of Gram-positive bacteria, the said compound compris... | 05/13/1986 |
| 4448714 | Antibiotic polypeptide compounds prepared from staphlococcus bacteria The invention relates to an antibiotic polypeptide compound, or addition salt thereof, having a molecular weight no greater than 10000 and possessing bactericidal and bacteriolytic activities in respect of Gram-positive bacteria, the said compound compris... | 05/15/1984 |
| 4309502 | Enzymatic assay for glycerol and triglycerides and a reagent for use therein An assay which is capable of determining the endogenous glycerol and endogenous triglycerides content of a sample without the necessity of performing a separate glycerol assay. The assay of the instant invention can be performed in a single cuvette and is... | 01/05/1982 |
| 4055468 | Processes for producing physiologically active peptide and its N-acyl derivatives A novel physiologically active peptide Val--X--Ala--X, in which X is 4-amino-3-hydroxy-6-methylheptanoic acid, which is prepared from R--Val--Val--X--Ala--X by the action of a microbial enzyme, N-acyl derivatives thereof which are produced by acylating sa... | 10/25/1977 |
| 4021305 | String culture inoculum The present invention is concerned with a string culture inoculum comprising a string having stabilized cells of one of dispersed throughout, said string culture inoculum having a sufficient number of stabilized cells adhered thereto to produce at least 10 | 05/03/1977 |
| 4014745 | Application of luciferase assay for ATP to antimicrobial drug susceptibility The susceptibility of bacteria, particularly those derived from body fluids, to antimicrobial agents is determined in terms of an ATP index measured by culturing a bacterium in a growth medium, assaying the amount of ATP in a sample of the cultured bacter... | 03/29/1977 |
| 4009078 | Detecting the presence of microorganisms The presence of microorganisms in a sample is determined by culturing microorganisms in a growth medium which is in contact with a measuring electrode and a reference electrode and detecting a change in potential between the electrodes caused by the prese... | 02/22/1977 |
| 3933592 | Method of detecting living microorganisms The presence or absence of living microorganisms is determined by treating a sample containing said microorganisms with an adenosine triphosphate reactive mixture containing luciferin, luciferase and a cation in the presence of oxygen and measuring the li... | 01/20/1976 |
